{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:20:58Z","timestamp":1788326458451,"version":"build-2803163510"},"reference-count":126,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok","award":["B.SUB.25.250"],"award-info":[{"award-number":["B.SUB.25.250"]}]},{"award":["B.SUB.25.250"],"award-info":[{"award-number":["B.SUB.25.250"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Allergies and diabetes mellitus are highly prevalent, frequently co-occurring diseases. Antihistamines, the first-line treatment for allergies, block H1 receptors but also exhibit anti-inflammatory and antioxidant properties that may improve glucose metabolism. This systematic review examined the evidence for the potential antidiabetic effects of commonly used first- and second-generation antihistamines. A comprehensive search of the PubMed database (1978\u2013May 2026) yielded 17 eligible in vivo, in vitro, clinical, and in silico studies. Most reports indicated that antihistamines improve glucose tolerance, insulin sensitivity, and insulin secretion. Proposed mechanisms include enhanced insulin release, mast cell stabilization, attenuation of immune-mediated responses, reduced nephron alteration, and improved incretin signalling. Although substantial heterogeneity in study designs limits direct comparisons, current evidence suggests a beneficial role of antihistamines in modulating glucose metabolism, particularly for patients managing both allergies and diabetes. These findings highlight the potential for drug repurposing. However, further well-designed clinical trials are required to ensure reproducibility, successful animal-to-human translation, and overall safety before clinical implementation.<\/jats:p>","DOI":"10.3390\/antiox15091098","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:05:26Z","timestamp":1788224726000},"page":"1098","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidiabetic Properties of Histamine H1 Receptor Antagonists: A Systematic Review"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2592-0880","authenticated-orcid":false,"given":"Micha\u0142","family":"Radzikowski","sequence":"first","affiliation":[{"name":"Students\u2019 Scientific Club \u201cBiochemistry of Lifestyle Diseases\u201d at the Department of Hygiene, Epidemiology and Environmental Health, Medical University of Bialystok, 2C Mickiewicza Street, 15-022 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5609-3187","authenticated-orcid":false,"given":"Mateusz","family":"Maciejczyk","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Environmental Health, Medical University of Bialystok, 2C Mickiewicza Street, 15-022 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13601-020-00366-3","article-title":"Highlights and Recent Developments in Allergic Diseases in EAACI Journals (2019)","volume":"10","author":"Bousquet","year":"2020","journal-title":"Clin. Transl. Allergy"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ng, A., and Boersma, P. (2023). Diagnosed Allergic Conditions in Adults: United States, 2021, National Center for Health Statistics.","DOI":"10.15620\/cdc:122809"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zablotsky, B., Black, L., and Akinbami, L. (2023). Diagnosed Allergic Conditions in Children Aged 0\u201317 Years: United States, 2021, National Center for Health Statistics.","DOI":"10.15620\/cdc:123250"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.anai.2010.08.005","article-title":"The Basics of Histamine Biology","volume":"106","author":"Lieberman","year":"2011","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1346-8138.1996.tb02694.x","article-title":"Histamine: The Quintessential Mediator","volume":"23","author":"Greaves","year":"1996","journal-title":"J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mar\u0161avelski, A., Mavri, J., Vianello, R., and Stare, J. (2022). Why Monoamine Oxidase B Preferably Metabolizes N-Methylhistamine over Histamine: Evidence from the Multiscale Simulation of the Rate-Limiting Step. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031910"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00894-009-0624-9","article-title":"Histamine (Re)Uptake by Astrocytes: An Experimental and Computational Study","volume":"16","author":"Mavri","year":"2010","journal-title":"J. Mol. Model."},{"key":"ref_8","first-page":"601","article-title":"International Union of Basic and Clinical Pharmacology","volume":"67","author":"Panula","year":"2015","journal-title":"XCVIII. Histamine Recept. Pharmacol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature10236","article-title":"Structure of the Human Histamine H1 Receptor Complex with Doxepin","volume":"475","author":"Shimamura","year":"2011","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature11896","article-title":"Molecular Signatures of G-Protein-Coupled Receptors","volume":"494","author":"Venkatakrishnan","year":"2013","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1038\/s41467-024-52585-y","article-title":"Structural Basis of Ligand Recognition and Activation of the Histamine Receptor Family","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0031-6997(25)00039-0","article-title":"Distribution, Properties, and Functional Characteristics of Three Classes of Histamine Receptor","volume":"42","author":"Hill","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejphar.2005.12.044","article-title":"Histamine Receptors Are Hot in Immunopharmacology","volume":"533","author":"Akdis","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-Antihistamines: Celebrating a Century of Progress","volume":"128","author":"Simons","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41467-023-44477-4","article-title":"Molecular Mechanism of Antihistamines Recognition and Regulation of the Histamine H1 Receptor","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-Antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_17","first-page":"101","article-title":"Antiallergic Anti-Inflammatory Effects of H1-Antihistamines in Humans","volume":"17","author":"Assanasen","year":"2002","journal-title":"Clin. Allergy Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2864","DOI":"10.1002\/hup.2864","article-title":"Efficacy and Safety of Hydroxyzine for Sleep in Adults: Systematic Review","volume":"38","author":"Burgazli","year":"2023","journal-title":"Hum. Psychopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Garakani, A., Murrough, J.W., Freire, R.C., Thom, R.P., Larkin, K., Buono, F.D., and Iosifescu, D. (2020). V Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.595584"},{"key":"ref_20","unstructured":"Southard, B.T., and Al Khalili, Y. (2024). Promethazine, StatPearls Publishing."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cao, M., and Gao, Y. (2024). Mast Cell Stabilizers: From Pathogenic Roles to Targeting Therapies. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1418897"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","article-title":"Rupatadine, a New Potent, Orally Active Dual Antagonist of Histamine and Platelet-Activating Factor (PAF)","volume":"280","author":"Merlos","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/WOX.0b013e318186fb3a","article-title":"H1 Antihistamines: Current Status and Future Directions","volume":"1","author":"Simons","year":"2008","journal-title":"World Allergy Organ. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2174\/1570161117666190405165911","article-title":"The Growing Epidemic of Diabetes Mellitus","volume":"18","author":"Lovic","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7748\/ns.2021.e11709","article-title":"Diabetes Mellitus: An Overview of the Types, Symptoms, Complications and Management","volume":"37","author":"Cloete","year":"2022","journal-title":"Nurs. Stand."},{"key":"ref_26","first-page":"B65","article-title":"Advanced Glycosylated End Products and Hyperglycemia in the Pathogenesis of Diabetic Complications","volume":"22","author":"Friedman","year":"1999","journal-title":"Diabetes Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1463-1326.2006.00595.x","article-title":"Advanced Glycation Endproducts: What Is Their Relevance to Diabetic Complications?","volume":"9","author":"Ahmed","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"ref_28","first-page":"337","article-title":"Non-Enzymatic Glycation of Proteins: A Cause for Complications in Diabetes","volume":"43","author":"Nawale","year":"2006","journal-title":"Indian J. Biochem. Biophys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/bs.acc.2022.11.003","article-title":"Protein Glycation in Diabetes Mellitus","volume":"113","author":"Shin","year":"2023","journal-title":"Adv. Clin. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Nakamura, A., and Kawaharada, R. (2022). Advanced Glycation End Products and Oxidative Stress in a Hyperglycaemic Environment. Fundamentals of Glycosylation, IntechOpen.","DOI":"10.5772\/intechopen.97234"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.14336\/AD.2017.1121","article-title":"Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging","volume":"9","author":"Fournet","year":"2018","journal-title":"Aging Dis."},{"key":"ref_32","first-page":"S8","article-title":"Glycation, Glycoxidation and Diabetes Mellitus","volume":"2","author":"Boulanger","year":"2006","journal-title":"Nephrol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Biedrzycki, G., Wolszczak-Biedrzycka, B., Dorf, J., and Maciejczyk, M. (2024). The Antioxidant Barrier, Oxidative\/Nitrosative Stress, and Protein Glycation in Allergy: From Basic Research to Clinical Practice. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1440313"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10654-005-7920-1","article-title":"The Association Between Allergy and Diabetes in the Canadian Population: Implications for the Th1-Th2 Hypothesis","volume":"20","author":"Dales","year":"2005","journal-title":"Eur. J. Epidemiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/oby.2010.176","article-title":"Association of Prescription H1 Antihistamine Use with Obesity: Results from the National Health and Nutrition Examination Survey","volume":"18","author":"Ratliff","year":"2010","journal-title":"Obesity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_37","first-page":"1","article-title":"PRISMA2020: An R Package and Shiny App for Producing PRISMA 2020-Compliant Flow Diagrams, with Interactivity for Optimised Digital Transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst. Rev."},{"key":"ref_38","unstructured":"(2026, July 07). Study Quality Assessment Tools|NHLBI, NIH, Available online: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., De Vries, R.B.M., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s Risk of Bias Tool for Animal Studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.prosdent.2022.05.019","article-title":"Development and Validation of a Risk-of-Bias Tool for Assessing in Vitro Studies Conducted in Dentistry: The QUIN","volume":"131","author":"Sheth","year":"2024","journal-title":"J. Prosthet. Dent."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(97)00126-X","article-title":"Antazoline Increases Insulin Secretion and Improves Glucose Tolerance in Rats and Dogs","volume":"324","author":"Berdeu","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/diacare.17.2.138","article-title":"Linear Loss of Insulin Secretory Capacity During the Last Six Months Preceding IDDM: No Effect of Antiedematous Therapy with Ketotifen","volume":"17","author":"Kolb","year":"1994","journal-title":"Diabetes Care"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0196-0644(85)81067-2","article-title":"Histamine Antagonists in the Treatment of Shock Hyperglycemia in the Rat","volume":"14","author":"Dimlich","year":"1985","journal-title":"Ann. Emerg. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2010.07.032","article-title":"Gatifloxacin-Induced Histamine Release and Hyperglycemia in Rats","volume":"645","author":"Ishiwata","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejphar.2006.08.081","article-title":"Effect of Levofloxacin on Serum Glucose Concentration in Rats","volume":"551","author":"Ishiwata","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopha.2017.10.085","article-title":"Evaluation of Diphenhydramine in Talc Induced Type 2 Diabetes Mellitus in Wistar Rats","volume":"97","author":"Afzal","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1507\/endocrj.EJ16-0458","article-title":"Role of Ketotifen on Metabolic Profiles, Inflammation and Oxidative Stress in Diabetic Rats","volume":"64","author":"Chen","year":"2017","journal-title":"Endocr. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jdiacomp.2015.01.013","article-title":"Effect of Ketotifen in Obese Patients with Type 2 Diabetes Mellitus","volume":"29","author":"Farrag","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nm.1994","article-title":"Genetic Deficiency and Pharmacological Stabilization of Mast Cells Reduce Diet-Induced Obesity and Diabetes in Mice","volume":"15","author":"Liu","year":"2009","journal-title":"Nat. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2016.03.035","article-title":"Comparison of the Effects of Levocetirizine and Losartan on Diabetic Nephropathy and Vascular Dysfunction in Streptozotocin-Induced Diabetic Rats","volume":"780","author":"Anbar","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejphar.2014.07.021","article-title":"Levocetirizine Ameliorates High Fructose Diet-Induced Insulin Resistance, Vascular Dysfunction and Hepatic Steatosis in Rats","volume":"740","author":"Shawky","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s11255-023-03804-w","article-title":"Repurposing Fexofenadine as a Promising Candidate for Diabetic Kidney Disease: Randomized Clinical Trial","volume":"56","author":"Ibrahim","year":"2023","journal-title":"Int. Urol. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"G217","DOI":"10.1152\/ajpgi.00321.2018","article-title":"Prolonged Intake of Desloratadine: Mesenteric Lymphatic Vessel Dysfunction and Development of Obesity\/Metabolic Syndrome","volume":"316","author":"Gasheva","year":"2019","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00210-020-01856-8","article-title":"Rupatadine, a Dual Antagonist of Histamine and Platelet-Activating Factor (PAF), Attenuates Experimentally Induced Diabetic Nephropathy in Rats","volume":"393","author":"Hafez","year":"2020","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MPA.0000000000000076","article-title":"The H1-Receptor Antagonist Cetirizine Protects Partially Against Cytokine- and Hydrogen Peroxide\u2013Induced \u03b2-TC6 Cell Death In Vitro","volume":"43","author":"Anvari","year":"2014","journal-title":"Pancreas"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/03009734.2014.967422","article-title":"The H1-Receptor Antagonist Cetirizine Ameliorates High-Fat Diet-Induced Glucose Intolerance in Male C57BL\/6 Mice, but Not Diabetes Outcome in Female Non-Obese Diabetic (NOD) Mice","volume":"120","author":"Anvari","year":"2015","journal-title":"Ups. J. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"116632","DOI":"10.1016\/j.biopha.2024.116632","article-title":"The Antiglycation Potential of H1 Receptor Antagonists\u2014In Vitro Studies in Bovine Serum Albumin Model and in Silico Molecular Docking Analyses","volume":"175","author":"Biedrzycki","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the Nervous System","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"R1442","DOI":"10.1152\/ajpregu.2001.281.5.R1442","article-title":"Histamine H1 Receptors Mediate the Anorectic Action of the Pancreatic Hormone Amylin","volume":"281","author":"Mollet","year":"2001","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"16438","DOI":"10.1038\/s41598-019-52590-y","article-title":"Blockade of Multiple Monoamines Receptors Reduce Insulin Secretion from Pancreatic \u03b2-Cells","volume":"9","author":"Nagata","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1249\/JES.0000000000000093","article-title":"The Intriguing Role of Histamine in Exercise Responses","volume":"45","author":"Luttrell","year":"2017","journal-title":"Exerc. Sport Sci. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.CIR.0000066697.19571.AF","article-title":"Histamine Upregulates Gene Expression of Endothelial Nitric Oxide Synthase in Human Vascular Endothelial Cells","volume":"107","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1165\/rcmb.2013-0254OC","article-title":"Histamine Stimulates Hydrogen Peroxide Production by Bronchial Epithelial Cells via Histamine H1 Receptor and Dual Oxidase","volume":"50","author":"Rada","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/00325481.1986.11699266","article-title":"Adverse Effects of Antihistamines","volume":"79","author":"Schuller","year":"1986","journal-title":"Postgrad. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13651501.2014.907919","article-title":"Assessment of the Effects of Antihistamine Drugs on Mood, Sleep Quality, Sleepiness, and Dream Anxiety","volume":"18","author":"Ozdemir","year":"2014","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/1939-4551-4-S3-S22","article-title":"Pharmacology of Antihistamines","volume":"4","author":"Church","year":"2011","journal-title":"World Allergy Organ. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0091-6749(87)80197-5","article-title":"Sedative Effects of Antihistamines","volume":"80","author":"Roth","year":"1987","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_68","first-page":"32","article-title":"Glucose-Induced Insulin Secretion and Alpha 2-Adrenergic Receptor Subtypes","volume":"121","author":"Hirose","year":"1993","journal-title":"J. Lab. Clin. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs0850671","article-title":"Role of Alpha 2-Adrenoceptors and Imidazoline-Binding Sites in the Control of Insulin Secretion","volume":"85","author":"Chan","year":"1993","journal-title":"Clin. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/PL00005070","article-title":"Imidazoline\/Guanidinium Binding Sites and Their Relation to Inhibition of K(ATP) Channels in Pancreatic B-Cells","volume":"356","author":"Rustenbeck","year":"1997","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.2337\/diabetes.53.suppl_3.S135","article-title":"Glucose Dependence of Imidazoline-Induced Insulin Secretion: Different Characteristics of Two ATP-Sensitive K+ Channel-Blocking Compounds","volume":"53","author":"Bleck","year":"2004","journal-title":"Diabetes"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/pr.55.1.7","article-title":"Pharmacological Agents That Directly Modulate Insulin Secretion","volume":"55","author":"Doyle","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/346274a0","article-title":"Mast Cells as a Source of Both Preformed and Immunologically Inducible TNF-\u03b1\/Cachectin","volume":"346","author":"Gordon","year":"1990","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood.V89.8.2654","article-title":"Differential Release of Mast Cell Interleukin-6 via c-Kit","volume":"89","author":"Gagari","year":"1997","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1432-1033.1993.tb18205.x","article-title":"Biosynthesis of Platelet-activating Factor in Cultured Mast Cells","volume":"216","author":"Colard","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1073\/pnas.82.19.6632","article-title":"Leukotriene C4 Production by Murine Mast Cells: Evidence of a Role for Extracellular Leukotriene A4","volume":"82","author":"Dahinden","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kozlov, A.V., Javadov, S., and Sommer, N. (2024). Cellular ROS and Antioxidants: Physiological and Pathological Role. Antioxidants, 13.","DOI":"10.3390\/antiox13050602"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cmet.2009.08.009","article-title":"Reactive Oxygen Species Enhance Insulin Sensitivity","volume":"10","author":"Loh","year":"2009","journal-title":"Cell Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4093\/dmj.2016.40.4.272","article-title":"Roles of Reactive Oxygen Species on Insulin Resistance in Adipose Tissue","volume":"40","author":"Han","year":"2016","journal-title":"Diabetes Metab. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00204-015-1520-y","article-title":"Interactions between Mitochondrial Reactive Oxygen Species and Cellular Glucose Metabolism","volume":"89","author":"Willems","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Mukai, E., Fujimoto, S., and Inagaki, N. (2022). Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic \u03b2-Cells. Biomolecules, 12.","DOI":"10.3390\/biom12091228"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Llanos, P., and Palomero, J. (2022). Reactive Oxygen and Nitrogen Species (RONS) and Cytokines\u2014Myokines Involved in Glucose Uptake and Insulin Resistance in Skeletal Muscle. Cells, 11.","DOI":"10.3390\/cells11244008"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1152\/physrev.00014.2008","article-title":"Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species","volume":"89","author":"Bashan","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0002-9440(10)62055-X","article-title":"Mast Cell-Deficient W-Sash c-Kit Mutant KitW-Sh\/W-Sh Mice as a Model for Investigating Mast Cell Biology in Vivo","volume":"167","author":"Grimbaldeston","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/01.ATV.17.5.963","article-title":"Platelet-Activating Factor and Oxidized LDL Induce Immune Activation by a Common Mechanism","volume":"17","author":"Huang","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1027314103063","article-title":"Platelet-Activating Factor Stimulates Interleukin-6 Production by Human Endothelial Cells and Synergizes with Tumor Necrosis Factor for Enhanced Production of Granulocyte-Macrophage Colony Stimulating Factor","volume":"21","author":"Lacasse","year":"1997","journal-title":"Inflammation"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1046\/j.1365-2222.1999.00703.x","article-title":"Anti-Inflammatory Actions of New Antihistamines","volume":"29","author":"Hayashi","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1161\/ATVBAHA.110.207373","article-title":"Effects of High-Density Lipoproteins on Pancreatic Beta-Cell Insulin Secretion","volume":"30","author":"Fryirs","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.108.843219","article-title":"High-Density Lipoprotein Modulates Glucose Metabolism in Patients with Type 2 Diabetes Mellitus","volume":"119","author":"Drew","year":"2009","journal-title":"Circulation"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.ATV.0000216600.37436.cf","article-title":"High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice","volume":"26","author":"Tso","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and Antithrombotic Actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory Properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R400001-JLR200","article-title":"The Oxidation Hypothesis of Atherogenesis: The Role of Oxidized Phospholipids and HDL","volume":"45","author":"Navab","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1016\/S0149-2918(03)90091-9","article-title":"Losartan and Other Angiotensin II Antagonists for Nephropathy in Type 2 Diabetes Mellitus: A Review of the Clinical Trial Evidence","volume":"25","author":"Ruilope","year":"2003","journal-title":"Clin. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Costantino, V.V., Gil Lorenzo, A.F., Bocanegra, V., and Vall\u00e9s, P.G. (2021). Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70. Cells, 10.","DOI":"10.3390\/cells10113146"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"109175","DOI":"10.1016\/j.jdiacomp.2025.109175","article-title":"Efficacy of Levocetirizine in Reducing Albuminuria and Inflammatory Biomarkers in Patients with Diabetic Kidney Disease: A Randomized Controlled Trial","volume":"39","author":"Rizk","year":"2025","journal-title":"J. Diabetes Complicat."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Verta, R., Grange, C., Gurrieri, M., Borga, S., Nardini, P., Argenziano, M., Gh\u00e8, C., Cavalli, R., Benetti, E., and Miglio, G. (2019). Effect of Bilastine on Diabetic Nephropathy in DBA2\/J Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102554"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7324\/JAPS.2019.90105","article-title":"Inhibition of Dipeptidyl Peptidase IV by Fexofenadine: Virtual Screening Study","volume":"9","author":"Almasri","year":"2019","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Deacon, C.F. (2019). Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00080"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199205143262003","article-title":"Antidiabetogenic Effect of Glucagon-like Peptide-1 (7-36)Amide in Normal Subjects and Patients with Diabetes Mellitus","volume":"326","author":"Gutniak","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.beem.2007.07.005","article-title":"DPP-4 Inhibitors","volume":"21","year":"2007","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Gallwitz, B. (2019). Clinical Use of DPP-4 Inhibitors. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00389"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Gilbert, M.P., and Pratley, R.E. (2020). GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00178"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.1901348","article-title":"Hyperglycemic Memory of Innate Immune Cells Promotes In Vitro Proinflammatory Responses of Human Monocytes and Murine Macrophages","volume":"206","author":"Thiem","year":"2021","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF00505187","article-title":"Pathogenesis of Low Dose Streptozotocin Induced Diabetes in Mice: Requirement for Alpha 1-Adrenoceptor Activation and Vasoactive Amine Release","volume":"32","author":"Martin","year":"1989","journal-title":"Diabetologia"},{"key":"ref_110","first-page":"G987","article-title":"Novel Insights into Histamine H2 Receptor Biology","volume":"273","author":"Gantz","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_111","first-page":"61","article-title":"Diagnosis and Treatment of Systemic Mastocytosis\u2014Experts\u2019 Statement","volume":"11","author":"Hus","year":"2020","journal-title":"Hematol. Clin. Pract."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Kou, E., Zhang, X., Dong, B., Wang, B., and Zhu, Y. (2024). Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy. Life, 14.","DOI":"10.3390\/life14020164"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"101942","DOI":"10.1016\/j.pupt.2020.101942","article-title":"Dual-Histamine Receptor Blockade with Cetirizine\u2014Famotidine Reduces Pulmonary Symptoms in COVID-19 Patients","volume":"63","author":"Hogan","year":"2020","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_114","first-page":"345","article-title":"Therapy of Cluster Headache with Histamine H1 and H2 Receptor Antagonists","volume":"18","author":"Cuypers","year":"1979","journal-title":"Eur. Neurol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.phrs.2016.06.021","article-title":"Histamine in Diabetes: Is It Time to Reconsider?","volume":"111","author":"Pini","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e00033","DOI":"10.1002\/phy2.33","article-title":"Effect of H1- and H2-Histamine Receptor Blockade on Postexercise Insulin Sensitivity","volume":"1","author":"Pellinger","year":"2013","journal-title":"Physiol. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/00007611-198205000-00041","article-title":"Combination H1 and H2 Receptor Antagonist Therapy in Diabetic Autonomic Neuropathy","volume":"75","author":"Stacpoole","year":"1982","journal-title":"South. Med. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4196\/kjpp.2014.18.1.41","article-title":"The Modulatory Role of Spinally Located Histamine Receptors in the Regulation of the Blood Glucose Level in D-Glucose-Fed Mice","volume":"18","author":"Sim","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Biedrzycki, G., Wolszczak-Biedrzycka, B., Dorf, J., Michalak, D., \u017bendzian-Piotrowska, M., Zalewska, A., and Maciejczyk, M. (2023). Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists-In Vitro Studies and a Systematic Literature Review. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091273"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of Animal Studies for Predicting Toxicity in Clinical Trials: Is It Time to Rethink Our Current Approach?","volume":"4","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_121","first-page":"910","article-title":"2D and 3D Cell Cultures\u2014A Comparison of Different Types of Cancer Cell Cultures","volume":"14","author":"Kolenda","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"117976","DOI":"10.1016\/j.biopha.2025.117976","article-title":"Inhibition of Protein Glycation by Vasodilatory \u03b2-Blockers\u2014In Vitro Studies and in Silico Analyses","volume":"185","author":"Radzikowski","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Sadowska-Bartosz, I., Galiniak, S., and Bartosz, G. (2014). Kinetics of Glycoxidation of Bovine Serum Albumin by Glucose, Fructose and Ribose and Its Prevention by Food Components. Molecules, 19.","DOI":"10.3390\/molecules191118828"},{"key":"ref_124","first-page":"578","article-title":"The Importance of In-Silico Studies in Drug Discovery","volume":"2","author":"Roney","year":"2024","journal-title":"Intell. Pharm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajg.2009.118","article-title":"Systematic Reviews: The Good, the Bad, and the Ugly","volume":"104","author":"Yuan","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/nae2.28","article-title":"Systematic Reviews: Brief Overview of Methods, Limitations, and Resources","volume":"31","author":"Owens","year":"2021","journal-title":"Nurse Author Ed."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/9\/1098\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:36:26Z","timestamp":1788323786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/9\/1098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":126,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["antiox15091098"],"URL":"https:\/\/doi.org\/10.3390\/antiox15091098","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}